China Glycine: Prelim Results of AD Admin Review
The International Trade Administration issued the preliminary results of its administrative review of the antidumping duty order on glycine from China (A-570-836) for one company, the Baoding Mantong Fine Chemistry Co. Because of Baoding Mantong's alleged lack of cooperation, the ITA used adverse facts available (AFA) to assign it the China-wide entity AD rate. The ITA also preliminarily rescinded this review with respect to 25 other companies1 named in the initiation of this review because of withdrawal of requests for review. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
| Exporter | AD Rate |
|---|---|
| China-wide Entity2 | 453.79% |
(The period of review is 03/01/11 -- 02/29/12. See ITA notice for additional information, including the scope of the order, potential cash deposit and assessment instructions, etc.)
1The 25 companies for which the ITA preliminarily rescinded this review are as follows: A&A Pharmachem Inc.; Advance Exports; AICO Laboratories India Ltd.; Avid Organics Pvt. Ltd.; Chiyuen International Trading Ltd.; E--Heng Import and Export Co., Ltd.; General Ingredient Inc.; Hebei Donghua Chemical General Corporation; Hebei Donghua Jiheng Fine Chemical Co., Ltd.; Jiangsu Dongchang Chemical; Jizhou City Huayang Chemical Co., Ltd.; Kissner Milling Co. Ltd.; Nantong Dongchang Chemical Industrial Co. Ltd.; Ningbo Create-Bio Engineering Co. Ltd.; Nutracare International; Paras Intermediates Pvt. Ltd.; Qingdao Samin Chemical Co., Ltd.; Ravi Industries; Salvi Chemical Industries; Shanghai Waseta International Trading; Showa Denko K.K.; Tianjin Tiancheng Pharmaceutical Company; Wisent Pharma Inc.; XPAC Technologies Inc.; and Yuki Gosei Kogyo Co., Ltd.
2Includes Baoding Mantong Fine Chemistry Co., Ltd.
ITA contact -- Brian Davis (202) 482-7924
(FR Pub 12/06/12)